EMA Authorised: Quinsair (levofloxacin) — Chiesi Farmaceutici S.p.A

View source ↗

Summary

The European Medicines Agency has authorised Quinsair (inhaled levofloxacin) by Chiesi Farmaceutici for use in cystic fibrosis and related respiratory tract inf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Respiratory Tract Infections

Drugs mentioned

• Quinsair (levofloxacin)

Snippet

Status: Authorised. Therapeutic area: Cystic Fibrosis;Respiratory Tract Infections. MAH: Chiesi Farmaceutici S.p.A. Decision date: 01/04/2025